Sequential Blood Purification for Pediatric Fatal Toxic Epidermal Necrolysis: A Case Series

Blood Purif. 2022;51(7):600-607. doi: 10.1159/000517088. Epub 2021 Sep 6.

Abstract

Background: Extracorporeal therapy that included therapeutic plasma exchange (TPE) or continuous hemofiltration (CHF) for toxic epidermal necrolysis (TEN) syndrome was used in small number of patients. We aimed to describe the sequential mode of combined application of CHF and TPE in 3 TEN patients with multiple organ dysfunction (MODS) in pediatric intensive care unit.

Methods: Three patients with fatal TEN received sequential CHF and TPE due to unsatisfactorily conventional treatments. CHF was initiated and performed on a daily basis with 35-50 mL/kg.h replacement fluid at the rate of 3-5 mL/kg.min blood flow. CHF was temporarily interrupted for TPE, which was performed with exchange 1-1.5-fold of one body calculated plasma volume in each section.

Results: All 3 fatal TEN (with >30% involvement of body surface and MODS) following unsuccessful treatment with corticosteroids and intravenous immunoglobulin. Antibiotics were suspected in the TEN-triggered drugs. The range number of TPE sessions was 3-5 and the duration of CHF was from 120 h to 202 h. After initiation of TPE and CHF, blistering with extensive epidermal necrosis halted and the skin re-epithelialized within 2 weeks. Serum C-reactive protein, procalcitonin, tumor necrosis factor-α , and interlukin-6 decreased and percentage of natural killer cells increased in surviving children. Two patients survived to discharge and one case died due to nosocomial infection with multidrug-resistant Acinetobacter baumannii.

Conclusion: After sequential TPE and CHF, skin lesions and inflammatory response improved in TEN. Our result indicates extracorporeal therapy could be used as an alternative modality for fatal pediatric TEN.

Keywords: Child; Hemofiltration; Pediatric intensive care unit; Therapeutic plasma exchange; Toxic epidermal necrolysis.

MeSH terms

  • Child
  • Humans
  • Immunoglobulins, Intravenous / therapeutic use
  • Multiple Organ Failure / etiology
  • Multiple Organ Failure / therapy
  • Plasma Exchange
  • Plasmapheresis
  • Retrospective Studies
  • Stevens-Johnson Syndrome* / drug therapy
  • Stevens-Johnson Syndrome* / pathology

Substances

  • Immunoglobulins, Intravenous